Precise Biometrics successfully completes private placement of approximately SEK 86 million

This press release may not be announced, published or distributed, directly or
indirectly in the United States, Canada, Japan, New Zealand, South Africa or
Australia.
Precise Biometrics AB (“Precise”) today announces that it has completed a
private placement of 22,000,000 new shares, providing the company with
approximately SEK 86 million before transaction costs.

The private placement, which was announced on the 5thof September, 2013, has
allowed Precise to place 22,000,000 new shares with international intuitional
investors and qualified investors in Sweden at a price of SEK 3.90 per share
through an accelerated book-building procedure.

The proceeds from the Private Placement will further enhance the company’s
working capital related to growth and order financing.

“We are excited about the interest shown by investors, both in Sweden and
internationally, and welcome them on board as shareholders. The transaction
strengthens our financial position and enables the Company to capitalize on the
exciting opportunities arising as the market grows and keep up the high tempo in
our current expansion”, says Thomas Marschall, President and CEO of Precise
Biometrics.

For the purpose of the private placement, the Board of Director of Precise has
resolved, pursuant to the authorization given by the 2013 annual general
meeting, on a directed issue of 22,000,000 new shares. The purpose of the
resolution to issue new shares, deviating from the shareholders’ preferential
rights, is primarily to take advantage of an opportunity to raise capital on
advantageous terms from new, from a financial perspective, strategically
important owners, thereby promoting Precise’s ability to create further value
for all shareholders.

The new issue results in an equity dilution of 6.4 based on the number of shares
after the new issue. The subscription price has been established through a
customary book-building procedure. In relation to the 10 day volume weighted
average share price on the 5thof September after market close, the subscription
price corresponds to a discount of 8 percent. In relation to the market close
price on the 5thof September, the subscription price corresponds to a discount
of 9 percent.

Through the issue, the number of shares in Precise increases by 22,000,000 from
323,306,094 shares to a total of 345,306,094 shares and the share capital
increases by SEK 6,160,000.00 from SEK 90,525,706.38 to a total of SEK
96,685,706.38

Advisor:
Carnegie Investment Bank served as financial advisor and bookrunner in
connection with the directed share issue.

Precise Biometrics AB (publ) may be required to disclose the information
provided herein pursuant to the Securities Markets Act. The information was
submitted for publication at 08:00am on September 6, 2013.

Important information
The publication or distribution of this press release may in certain
jurisdictions be subject to restriction by law, and persons in the jurisdictions
where this press release has been published or distributed should inform
themselves of and follow such legal restrictions. This press release does not
contain or constitute an invitation or offer to acquire, subscribe to or
otherwise trade with shares, subscription rights or other securities in Precise
Biometrics.

This press release may not be made public, published or distributed, either
directly or indirectly in the United States, Canada, Japan, New Zealand, South
Africa, Australia or any other country where such procedures are subject in full
or in part to legal restrictions. Nor may the information in this press release
may not be communicated, reproduced or presented in any way that is in conflict
with such restrictions. Failure to follow this instruction may involve a breach
of the United States Securities Act from 1933 ("Securities Act") or applicable
laws in other jurisdictions.

This press release may contain forward-looking statements. When used in this
press release, words such as “evaluate”, “expect” and “intend” are intended to
identify forward-looking statements. They may involve risks and uncertainties,
including product demand and market acceptance, the effect of economic
conditions, the impact of competitive products and pricing, foreign currency
exchange rates and other risks. These forward-looking statements reflect the
views of the management as of the date made with respect to future events and
are subject to risks and uncertainties. All of these forward-looking statements
are based on estimates and assumptions made by the management and are believed
to be reasonable, though are inherently uncertain and difficult to predict.
Actual results or experience could differ materially from the forward-looking
statements. Precise Biometrics disclaims any intention or obligation to update
these forward-looking statements.

FOR FURTHER INFORMATION, PLEASE CONTACT
Thomas Marschall, President and CEO, Precise Biometrics AB
Telephone; +46 46 31 11 10 or +46 734 35 11 10, E-mail;
thomas.marschall@precisebiometrics.com

Patrik Norberg, CFO, Precise Biometrics AB
Telephone; +46 46 31 11 47 or +46 734 35 11 47, E-mail;
patrik.norberg@precisebiometrics.com

Precise Biometrics is a market-leading provider of solutions for fingerprint
recognition to prove people's identities. With top-of-the-line expertise in
fingerprint verification, Precise Biometrics offers fast, accurate and secure
authentication of a person.

The technology adds value to ID, enterprise and bank cards as well as access to
mobile solutions, computers and networks. Precise Biometrics serves business and
government organizations throughout the world and its technology is licensed to
close to 160 million users.

For more information, please visit www.precisebiometrics.com